Radiofrequency ablation in the treatment of small hepatocellular carcinoma: a meta analysis

World J Gastroenterol. 2010 Jul 21;16(27):3450-6. doi: 10.3748/wjg.v16.i27.3450.

Abstract

Aim: To evaluate survival and recurrence after radiofrequency ablation (RFA) for the treatment of small hepatocellular carcinoma (HCC) using a meta-analysis.

Methods: Literature on RFA vs surgical resection for the treatment of small HCC published between January 1990 and December 2008 was retrieved. A meta-analysis was conducted to estimate pooled survival and recurrence ratios. A fixed or random effect model was established to collect the data.

Results: The differences in overall survival at 1-year, 3-years and at end of follow-up were not statistically significant between the RFA and surgery groups (P > 0.05). There were no differences in 1-year and 3-year recurrences between the RFA and surgery groups (P > 0.05). However, recurrence in the RFA group was lower than that in the surgery group up to the end of follow-up (P = 0.03). Survival was not significantly different. There was a significant difference in recurrences at the end of follow-up after RFA compared with surgical resection.

Conclusion: RFA did not decrease the number of overall recurrences, and had no effect on survival when compared with surgical resection in a selected group of patients.

Publication types

  • Meta-Analysis

MeSH terms

  • Bias
  • Carcinoma, Hepatocellular* / pathology
  • Carcinoma, Hepatocellular* / prevention & control
  • Carcinoma, Hepatocellular* / therapy
  • Catheter Ablation / methods*
  • Catheter Ablation / statistics & numerical data
  • Hepatectomy / methods
  • Hepatectomy / statistics & numerical data
  • Humans
  • Liver Neoplasms* / pathology
  • Liver Neoplasms* / prevention & control
  • Liver Neoplasms* / therapy
  • Neoplasm Recurrence, Local
  • Odds Ratio
  • Sensitivity and Specificity
  • Survival Rate
  • Treatment Outcome